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Introduction
Hepatic tumours represent one per cent of all paediatric 
malignancies and five per cent of all extracranial solid 
tumours. The liver is the third most common site of intra-
abdominal malignancies, following adrenal neuroblastoma 
and Wilms’ tumours.1 Significant perioperative morbidity 
and mortality have been quoted to be high as 19% in one 
publication.2 However, recent advances in anaesthesia and 
surgical management have significantly reduced operative 
risk. This review will attempt to focus on aspects of 
management that are important to the anaesthestist.
Presentation 
Seventy to eighty per cent of all primary liver tumours in 
children are malignant. Hepatoblastoma and hepatocellular 
carcinoma are the most common (Table I). Benign tumours 
are rare and the majority consist of haemangiomas or 
haemangioendotheliomas.2,3
Children with hepatic tumours present with abdominal 
distention, a palpable abdominal mass, or both. Anaemia, 
thrombocytopaenia and leukocytosis are sometimes 
present. Children with hepatoblastoma and hepatocellular 
carcinoma may also present with weight loss, fever and 
anorexia. As the tumour grows, pain may progress to the 
shoulder. 
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Abstract
Children presenting for liver resection form a challenging population with co-morbidities that require adequate preoperative 
assessment and planning to improve postoperative outcomes. With the development of new surgical equipment and 
techniques, the anaesthestist is in a precarious position in which a delicate balance is needed between delivering organ-
protective anaesthesia and providing haemodynamic stability that will allow for optimal surgical results. This review will 
highlight some of these aspects. 
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Table I: Lesions of the liver in children4-6
Malignant
1. Liver cell carcinoma
•	 Hepatoblastoma 
•	 Hepatocellular carcinoma 





1. Tumour-like epithelial lesions
•	 Focal nodular hyperplasia
•	 Multiple nodular hyperplasia
•	 Accessory lobe
2. Benign epithelial tumours
•	 Adenoma
•	 Adrenal rest tumours
3. Cysts and tumour-like mesenchymal tumours
•	 Mesenchymal harmatoma
•	 Nonparasitic cysts, e.g. hydatid and choledochal cysts
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Tumour growth may compress or obstruct the normal 
hepatic architecture, causing: 
•	 Ascites secondary to occlusion of the portal or hepatic 
veins.
•	 Gastrointestinal bleeding or splenomegaly from portal 
hypertension, portal vein occlusion or jaundice.
•	 Scleral icterus and pruritus from obstruction of the biliary 
tree.7
Preoperative workup
Biochemical tests include a full blood count, urea and 
electrolytes, liver enzyme levels, liver synthetic function and 
alpha-fetoprotein (AFP) levels. AFP is the most important 
tumour marker, whose levels are elevated in 50-70% of 
children with hepatic neoplasms.7 Multiple studies confirm 
that AFP is a valuable surveillance marker in children who 
have previously undergone liver resection for malignancy, 
those with unfavourable tumour biology, poor response 
to chemotherapy and poor outcomes.1,7 Since complete 
surgical resection offers the only possibility of permanent 
cure, imaging studies are of utmost importance. Ultrasound 
and Doppler imaging can be used to localise the tumour 
and evaluate the patency of the inferior vena cava (IVC), 
hepatic veins and portal vein. Magnetic resonance imaging, 
computed tomography scan and an angiography of the 
abdomen and chest are generally used for indeterminate 
or solid lesions to further delineate the location, extent 
and multiplicity of the lesions, and to detect vascular 
involvement and metastases (Figure 1).1,7
Surgical technique
The surgical aim is to excise the diseased part of the liver with 
adequate oncological clearance, minimal blood loss, and 
preservation of enough healthy liver to avoid liver failure and 
allow regeneration. The surgical procedure can be divided 
into two distinct phases: pre- and post-resection.6 Safe 
resection can be obtained through a generous transverse 
abdominal incision. It is rarely necessary to enter the 
thoracic cavity in children, even for resection of the largest 
hepatic tumours.5 The first step in resection is mobilisation 
of the liver by dividing its ligamentous attachments to the 
abdominal wall and diaphragm. The liver can be displaced 
almost out of the abdominal cavity in smaller children, to 
provide access to the retrohepatic vena cava. This may be 
associated with a sudden fall in cardiac output and central 
venous pressure, which necessitates repositioning the liver 
into its normal anatomical position until stability returns. The 
next step is isolation of the portal vein, common bile duct, 
and hepatic artery from the lobes and segments that are 
being resected.5 Extreme care to protect the vascular and 
biliary structures to the remaining portion of the liver has 
to be exercised. Ligation of the hepatic veins is the most 
difficult and hazardous part of the surgery. Avulsion or injury 
of the hepatic veins can result in massive haemorrhage. 
Several vascular occlusive techniques have been used in 
an attempt to minimise blood loss at this stage. Options 
include inflow vascular occlusion and a combination of 
inflow and outflow vascular exclusion manoeuvres (Table II).
Table II: Vascular occlusive techniques8
Inflow vascular occlusion
•	 Hepatic pedicle occlusion: Continuous Pringle manoeuvre and 
intermittent Pringle manoeuvre
•	 Selective inflow occlusion
Inflow and outflow vascular exclusion
•	 Total hepatic vascular exclusion 
•	 Inflow occlusion with extraparenchymal control of the major 
hepatic veins, with selective hepatic hepatic vascular exclusion or 
hepatic vascular exclusion with preservation of caval flow
Haemodynamic consequences
Both the common hepatic artery and portal vein are 
controlled in the hepatoduodenal ligament (Figure 2) 
using the Pringle manoeuvre. The liver can tolerate up to 
60 minutes of continuous occlusion and 120 minutes of 
intermittent occlusion.6  
Figure 1: Computed tomography scan showing right lobe 
hepatoblastoma compressing the inferior vena cava
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Selective inflow occlusion with hepatic artery and venous 
inflow isolation has far greater popularity as it allows normal 
inflow to the remaining liver segment, while preventing 
ischaemia and reducing bleeding during the parenchymal 
transection.
Inflow vascular occlusion has been associated with an 
increase in systemic vascular resistance of up to 40%, 
a 10% reduction in cardiac output and a mean arterial 
pressure increase of approximately 15% in the adult 
population.8 Following unclamping, haemodynamic 
parameters gradually return to baseline values. 
Total vascular exclusion combines portal vessel clamping 
with occlusion of the supra- and infrahepatic IVC, with 
significant haemodynamic consequences. The rapid 
haemodynamic changes are due to surgical events, such as 
caval clamping, sudden blood loss and hepatic reperfusion. 
Cross-clamping of the IVC and portal vein results in a 
40-60% reduction in venous return and cardiac output, 
with a compensatory 80% increase in systemic vascular 
resistance and a 50% increase in heart rate.6,8 Although 
systemic vascular resistance and heart rate increase, the 
cardiac index is reduced by half secondary to the preload 
reduction.8 Unclamping is followed by an increase in cardiac 
index and a significant reduction in systemic vascular 
resistance.6,8 
New surgical devices have been developed to facilitate 
bloodless transaction without the need for vascular 
occlusion. This includes ultrasonic cutting and coagulation 
devices, pressurised jets of water, the LigaSure™ Vessel 
Sealing System dissecting sealer and endoscopic staplers.9 
With these new techniques, up to 75% of the liver 
parenchyma can be resected with maintenance of normal 
liver function postoperatively. 
Anaesthetic considerations
Preoperative assessment
Preoperative assessment should be 
adapted to the needs of each individual 
patient, based on general co-morbidities 
and hepatic function. This should include 
routine blood workup and radiological 
imaging. Pre-existing hepatic impairment 
is a risk factor, with even higher blood 
transfusion requirements, longer hospital 
stay and increased mortality. It must also 
be remembered that a number of patients 
presenting for resection will have received 
neoadjuvant chemotherapy, commonly 
cisplatin, doxorubicin, vincristine or 
5-fluorouracil.4,5  These have multiple sys-
temic effects which may reduce functional reserve. A 
thorough cardiorespiratory assessment is necessary in 
these cases. 
Conduct of anaesthesia
Liver resection is conducted under general anaesthesia with 
tracheal intubation and mechanical ventilation.9 Patients 
with ascites should undergo rapid sequence induction. 
Cisatracurium and atracurium are the nondepolarising 
agents of choice in these patients because of their 
non-liver-dependent metabolism. The most commonly 
used volatile agents in an oxygen/air mixture include 
desflurane, sevoflurane and isoflurane. Isoflurane has a 
mild cardiodepressive effect, but maintains hepatic oxygen 
supply because of vasodilatation in the hepatic artery and 
portal vein. They all upregulate haeme oxygenase-1, release 
iron and carbon monoxide, and thus decrease portal 
vein blood flow, but increase hepatic artery blood flow. 
Some studies imply that ischaemic preconditioning with 
sevoflurane before inflow occlusion limits postoperative 
liver injury.8 An advantage of the usage of desflurane is 
that it undergoes only minor biodegradation, and may 
cause less hepatocellular damage because of its reduced 
metabolism. Nitrous oxide should be avoided as it causes 
gut distention and there is a small risk of air embolism. 
Antibiotic prophylaxis is given routinely, although local 
policy may suggest the most suitable choice.
Monitoring
Invasive arterial and central venous pressure monitoring 
allows for haemodynamic control and regular blood 
sampling as rapid catastrophic bleeding is possible. 
Large-bore intravenous access must be established and 
a rapid infusion system should be immediately available. 
Central venous pressure (CVP) monitoring may not be 
reliable during liver resections because of the pressure 
exerted by surgical retractors on the diaphragm, increasing 
IVC: inferior vena cava





Total inflow occlusion (Pringle)
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intrathoracic pressure, and consequently CVP.10 Clamping 
of the liver vessels reduces the venous return to the heart 
and therefore decreases CVP.10 In addition, changes in 
patient position and intrathoracic pressure by positive 
end expiratory pressure and intermittent positive pressure 
ventilation have thrown more doubt on the usefulness of 
this monitor during hepatic surgery.11 Transoesophageal 
echocardiography, pulmonary artery catheterisation 
and arterial waveform-based techniques have all been 
suggested for cardiac monitoring. Hypoglycaemia is a 
real concern, especially during hepatic vascular occlusion 
and after specimen resection, so blood glucose should be 
closely monitored. Nasogastric and nasojejunal tubes are 
inserted to enable postoperative stomach drainage and 
enteral feeding. Intraoperative coagulopathy should be 
monitored and appropriately corrected.10 
Haemodynamic management
Inflow vascular occlusion
Continuous Pringle manoeuvre, intermittent Pringle 
manoeuvre and selective inflow occlusion share common 
haemodynamic management. Anaesthetic management is 
dictated by the surgical approach and the patient’s health 
status. A low CVP of between 2 and 5 mmHg, while aiming 
for euvolaemia, forms the cornerstone of strategies to 
minimise bleeding.6,8-10 This is often a point of heated debate 
because of the fallacy that CVP is a monitor during this type 
of surgery.10 This can be achieved with the limitations of 
intravenous fluids, ensuring diuresis, and if ineffective, usage 
of vasoactive agents like nitroglycerine.8-10 The advantages 
of a low CVP must be weighed against inadequate perfusion 
of the vital organs and loss of volaemic reserve in the case 
of bleeding and/or air embolism. 
Inflow and outflow vascular occlusion
Total hepatic vascular exclusion (THVE) leads to preload 
reduction and a sudden decrease in cardiac output evoked 
by the IVC and portal vein clamping. Prior to this taking place, 
the anaesthestist must take prompt steps to correct the 
volume deficit, improve splanchnic circulation, displace fluid 
into the bowel compartment and reduce bowel oedema.8 
Blood pressure and circulatory support is achieved by 
aiming for a CVP of at least 14 mmHg.8 Vasoactive agents 
are administered if volume loading is inadequate to maintain 
blood pressure following clamping of the IVC. There is no 
standard approach to the use of vasoactive agents. They 
have to be used carefully, as they may improve cardiac 
output at the expense of microcirculatory blood flow. 
Perioperative fluid shifts, intravascular hypovolaemia and 
sympathetic activation during THVE result in the reduction 
of renal blood flow. Mannitol, furosemide and “low-dose 
dopamine” have been used with the aim of preventing 
intraoperative renal injury, without evidence of substantial 
benefit.8 It is essential to perform a manual test clamp prior 
to formally applying clamps as 10-15% of patients become 
significantly haemodynamically intolerant, requiring 
venovenous bypass. Haemodynamic intolerance to THVE 
or ischaemia under THVE exceeding 30-60 minutes may 
also require venovenous bypass. THVE should be limited 
to selected cases as haemodynamic intolerance has 
implications with regard to morbidity and extended hospital 
stay.
Selective hepatic vascular exclusion (SHVE) is favoured 
by many institutions as the standard method of vascular 
control because it provides a bloodless surgical field and is 
generally well tolerated by patients.6,8 Special anaesthetic 
considerations with regard to haemodynamic management 
of SHVE are similar to those for inflow vascular occlusion 
techniques, as this method diminishes blood pressure and 
heart rate fluctuations during liver resection. SHVE is the 
method of choice in cases when CVP cannot be lowered, 
and a very high or refractory CVP persists, such as in right 
heart failure, poor cardiovascular status, or when the tumour 
encroaches on the IVC.  
Blood-sparing techniques
Intraoperative blood salvage should be used during major 
liver resection. However, with the advent of new surgical 
equipment and vaso-occlusive techniques, blood loss 
is kept at a minimum. The use of aprotinin has led to 
significant reductions in blood transfusion requirements in 
liver transplants and resections. Caution has been advised 
against routine use of this agent12 because of serious 
safety concerns pertaining to the raised incidence of life-
threatening allergic reactions, thrombotic potential and 
renal failure. Tranexamic acid usage has been shown to 
reduce blood requirements in liver transplant and resection 
surgery, although safety concerns have not been proved.8,12 




The use of caudal or epidural analgesia has been shown 
to be highly effective in controlling postoperative pain, 
following elective liver resection. Boluses or continuous 
infusions of opiods with or without local anaesthesia 
protocols have been proposed.10 It may be argued that there 
could be an incidence of catastrophic complications in this 
population if there is pre-existing coagulopathy or massive 
blood loss.9,10 Thus, the decision to use regional anaesthesia 
must be individualised according to preoperative state and 
predicted intraoperative course.
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Intravenous analgesia
A combination of paracetamol, opiates, ketamine 
and nonsteroidal anti-inflammatories (NSAIDs) may 
be considered. Paracetamol significantly reduces the 
requirements for morphine postoperatively, despite its 
propensity to cause liver failure because of its hepatotoxic 
metabolite. It is safe in all but the most extensive liver 
resections. NSAIDs are likely to worsen pre-existing renal 
dysfunction (frequently associated with liver resections), 
and should therefore be used with caution.10
Vascular air embolism
Factors predisposing to vascular air embolism during liver 
resection include surgical technique, size and site of the 
tumour, blood loss and low CVP techniques. Resections 
of large tumours in the right lobe, close to the IVC or 
the cavohepatic junction, also put patients at risk of air 
embolism.8 The morbidity and mortality of air embolism 
depends on the volume and rate of air accummulation. 
Currently, the most sensitive monitoring devices for vascular 
air embolism are transoesophageal echocardiography and 
precordial Doppler ultrasonography, detecting as little as 
0.02 ml/kg and 0.05 ml/kg of air, respectively.8 The relative 
risk of vascular air embolism is low, and can be managed 
by placing the child in the Trendelenburg position. Attempts 
can be made to aspirate the air through a central venous 
catheter if in place, although its value may be limited. 
Supportive therapy is warranted in the form of fluid 
resuscitation and vasopressors.8,13 
Postoperative care
Most patients can be extubated and nursed in an 
intensive care unit where expected complications, such 
as hypoglycaemia, respiratory insufficiency, pain, ascites, 
infection, bleeding, coagulopathy, portal and hepatic vein 
thrombosis, renal dysfunction and postoperative liver 
dysfunction can be carefully monitored.5,12 
Conclusion
Liver resections undoubtedly require management 
in a multidisciplinary environment, in which there is 
communication between the oncologist, paediatric surgeon 
and anaesthetist. It has been speculated that liver resection 
in children is easier in some respects than it is in adults, 
in particular with regard to exposure, mobility of the organ, 
elasticity of the surrounding viscera, and the parenchymal 
mass which must be traversed, making it a simpler technical 
operation.5 On the other hand, little has been published 
on the anaesthetic management of liver resections in the 
paediatric population, and most conclusions about the 
management thereof are extrapolated from adult studies. 
Monitoring, accurate blood replacement, awareness of 
the child’s vulnerability to cardiac arrest, and thorough 
knowledge of surgical technique, are all highly important 
facets of successful hepatic surgery in children.
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